This paper presents an interesting trial of a possible screening programme for oral cancer in Taiwan. Oral cancers are a significant group of diseases worldwide being the sixth most common cancer and accounting for about 4% of cancers, and in some parts of the world the incidence is increasing. 1-2 There is strong evidence that tobacco use, alcohol consumption and betel quid chewing are the main risk factors in the aetiology of intraoral cancer. 
Question: Does the use of toluidine blue as an adjunctive tool for visual screening of the mouth result in the increased detection of oral premalignant lesions (OPMLs)? It should be borne in mind that the aim of this study was to identify OPMLs and not oral cancer per se and it may well be that the PPVs for identifying OPMLs is higher that 5% indicating that the test may have some utility. While screening may identify OPMLs that require further management, screening may also have potential negative effects. Screening whether on an individual or population perspective is far from perfect , and there are four potential outcomes from any test;
• true positive (correctly identified as positive),
• true negative (correctly identified as negative
• false positive (incorrectly identified as positive)
• false negative (incorrectly identified as negative)
False negatives can provide a false sense of security and perpetuate bad habits or delay final diagnosis.
False positives can cause stress and anxiety and lead to unnecessary additional appointments, tests and investigations. From the data presented we are unable to calculate the false negative proportions for OPMLs but if we consider those in this study who screen positive but are subsequently found to be have no lesions or a nonOPMLs to be negative, then the proportion of false positives was about 42% in each group.
Based on the evidence presented in the paper I find it difficult to agree with the conclusions that toluidine blue dye is more effective than visual screening alone. What I find more interesting is that the placebo dye is almost as effective. Overall this study, which has been published since the most recent update of the Cochrane review on oral cancer screening and the clinical recommendations from the ADA on oral cancer screening, does little to change my view that formal screening programmes for oral cancer are not a public health intervention that I would support.
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